TY  - JOUR
AU  - Zozaya, Néboa
AU  - Arrizubieta Basterrechea, Maria Iciar
AU  - Bollo, Elena
AU  - Castellví, Iván
AU  - Espín, Jaime
AU  - Ortego, Norberto
AU  - Poveda-Andrés, José Luis
AU  - Rodríguez Portal, José Antonio
AU  - Rivero, Agustín
AU  - Marcos-Rodríguez, José Antonio
AU  - Verde, Luis
PY  - 2022
DO  - 10.1017/S0266462322000459
UR  - http://hdl.handle.net/10668/22578
T2  - International journal of technology assessment in health care
AB  - Our aim was to assess the value of nintedanib for non-idiopathic progressive fibrosing interstitial lung disease (non-IPF PF-ILD) and systemic sclerosis-associated ILD (SSc-ILD) in the Spanish context, using a multi-criteria decision analysis (MCDA)....
LA  - en
PB  - Cambridge University Press
KW  - Interstitial lung diseases
KW  - Multi-criteria decision analysis
KW  - Pulmonary fibrosis
KW  - Systemic sclerosis
KW  - Decision Support Techniques
KW  - Disease Progression
KW  - Humans
KW  - Indoles
KW  - Lung Diseases, Interstitial
KW  - Reproducibility of Results
TI  - A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
TY  - research article
VL  - 38
ER  -